Genomic Health Continues International Push, Invests in Two Startups amid Double-Digit Q1 Revenue Growth

The company plans to take advantage of the double-digit growth rates it is seeing in the US market "to fund higher levels of investment in our international business, where market development activities are focused on physician education and payor reimbursement programs."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.